Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 42

    1.

    Sympathetic Tone in the Young. The Mother Weighs In.

    Rahmouni K.

    Hypertension. 2009 Nov 9. [Epub ahead of print] No abstract available. PMID: 19901157 [PubMed - as supplied by publisher]Related articles

    2.

    Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet-induced obesity.

    Nogueiras R, Pérez-Tilve D, Veyrat-Durebex C, Morgan DA, Varela L, Haynes WG, Patterson JT, Disse E, Pfluger PT, López M, Woods SC, DiMarchi R, Diéguez C, Rahmouni K, Rohner-Jeanrenaud F, Tschöp MH.

    J Neurosci. 2009 May 6;29(18):5916-25.PMID: 19420258 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Requirement of Bardet-Biedl syndrome proteins for leptin receptor signaling.

    Seo S, Guo DF, Bugge K, Morgan DA, Rahmouni K, Sheffield VC.

    Hum Mol Genet. 2009 Apr 1;18(7):1323-31. Epub 2009 Jan 15.PMID: 19150989 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Leptin signaling in the nucleus tractus solitarii increases sympathetic nerve activity to the kidney.

    Mark AL, Agassandian K, Morgan DA, Liu X, Cassell MD, Rahmouni K.

    Hypertension. 2009 Feb;53(2):375-80. Epub 2008 Dec 22.PMID: 19103999 [PubMed - indexed for MEDLINE]Related articles

    5.

    Hypothalamic ERK mediates the anorectic and thermogenic sympathetic effects of leptin.

    Rahmouni K, Sigmund CD, Haynes WG, Mark AL.

    Diabetes. 2009 Mar;58(3):536-42. Epub 2008 Dec 9.PMID: 19066310 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Mechanisms mediating renal sympathetic activation to leptin in obesity.

    Morgan DA, Thedens DR, Weiss R, Rahmouni K.

    Am J Physiol Regul Integr Comp Physiol. 2008 Dec;295(6):R1730-6. Epub 2008 Sep 24.PMID: 18815209 [PubMed - indexed for MEDLINE]Related articles

    7.

    Id3, E47, and SREBP-1c: fat factors controlling adiponectin expression.

    Rahmouni K, Sigmund CD.

    Circ Res. 2008 Sep 12;103(6):565-7. Review. No abstract available. PMID: 18796641 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Does genetic variation in the leptin receptor influence the sympathetic tone in obesity?

    Rahmouni K.

    Hypertens Res. 2008 Jun;31(6):1057-9. No abstract available. PMID: 18716350 [PubMed - indexed for MEDLINE]Related articles

    9.

    Leptin resistance contributes to obesity and hypertension in mouse models of Bardet-Biedl syndrome.

    Rahmouni K, Fath MA, Seo S, Thedens DR, Berry CJ, Weiss R, Nishimura DY, Sheffield VC.

    J Clin Invest. 2008 Apr;118(4):1458-67.PMID: 18317593 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Enhanced leptin-stimulated Pi3k activation in the CNS promotes white adipose tissue transdifferentiation.

    Plum L, Rother E, Münzberg H, Wunderlich FT, Morgan DA, Hampel B, Shanabrough M, Janoschek R, Könner AC, Alber J, Suzuki A, Krone W, Horvath TL, Rahmouni K, Brüning JC.

    Cell Metab. 2007 Dec;6(6):431-45.PMID: 18054313 [PubMed - indexed for MEDLINE]Related articles

    11.

    A knockin mouse model of the Bardet-Biedl syndrome 1 M390R mutation has cilia defects, ventriculomegaly, retinopathy, and obesity.

    Davis RE, Swiderski RE, Rahmouni K, Nishimura DY, Mullins RF, Agassandian K, Philp AR, Searby CC, Andrews MP, Thompson S, Berry CJ, Thedens DR, Yang B, Weiss RM, Cassell MD, Stone EM, Sheffield VC.

    Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19422-7. Epub 2007 Nov 21.PMID: 18032602 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The central melanocortin system directly controls peripheral lipid metabolism.

    Nogueiras R, Wiedmer P, Perez-Tilve D, Veyrat-Durebex C, Keogh JM, Sutton GM, Pfluger PT, Castaneda TR, Neschen S, Hofmann SM, Howles PN, Morgan DA, Benoit SC, Szanto I, Schrott B, Schürmann A, Joost HG, Hammond C, Hui DY, Woods SC, Rahmouni K, Butler AA, Farooqi IS, O'Rahilly S, Rohner-Jeanrenaud F, Tschöp MH.

    J Clin Invest. 2007 Nov;117(11):3475-88.PMID: 17885689 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The -20 and -217 promoter variants dominate differential angiotensinogen haplotype regulation in angiotensinogen-expressing cells.

    Dickson ME, Zimmerman MB, Rahmouni K, Sigmund CD.

    Hypertension. 2007 Mar;49(3):631-9. Epub 2007 Jan 2.PMID: 17200439 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Hypothalamic arcuate nucleus mediates the sympathetic and arterial pressure responses to leptin.

    Rahmouni K, Morgan DA.

    Hypertension. 2007 Mar;49(3):647-52. Epub 2006 Dec 26.PMID: 17190874 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome.

    Correia ML, Rahmouni K.

    Diabetes Obes Metab. 2006 Nov;8(6):603-10. Review.PMID: 17026484 [PubMed - indexed for MEDLINE]Related articles

    16.

    Lack of dilator effect of leptin in the hindlimb vascular bed of conscious rats.

    Rahmouni K, Jalali A, Morgan DA, Haynes WG.

    Eur J Pharmacol. 2005 Aug 22;518(2-3):175-81.PMID: 16054621 [PubMed - indexed for MEDLINE]Related articles

    17.

    Endothelial effects of leptin: implications in health and diseases.

    Rahmouni K, Haynes WG.

    Curr Diab Rep. 2005 Aug;5(4):260-6. Review.PMID: 16033675 [PubMed - indexed for MEDLINE]Related articles

    18.

    Role of selective leptin resistance in diet-induced obesity hypertension.

    Rahmouni K, Morgan DA, Morgan GM, Mark AL, Haynes WG.

    Diabetes. 2005 Jul;54(7):2012-8.PMID: 15983201 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    How do calcimimetics fit into the management of parathyroid hormone, calcium, and phosphate disturbances in dialysis patients?

    Shahapuni I, Mansour J, Harbouche L, Maouad B, Benyahia M, Rahmouni K, Oprisiu R, Bonne JF, Monge M, El Esper N, Presne C, Moriniere P, Choukroun G, Fournier A.

    Semin Dial. 2005 May-Jun;18(3):226-38. Review.PMID: 15934970 [PubMed - indexed for MEDLINE]Related articles

    20.

    Mkks-null mice have a phenotype resembling Bardet-Biedl syndrome.

    Fath MA, Mullins RF, Searby C, Nishimura DY, Wei J, Rahmouni K, Davis RE, Tayeh MK, Andrews M, Yang B, Sigmund CD, Stone EM, Sheffield VC.

    Hum Mol Genet. 2005 May 1;14(9):1109-18. Epub 2005 Mar 16.PMID: 15772095 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Loss of leptin actions in obesity: two concepts with cardiovascular implications.

    Mark AL, Correia ML, Rahmouni K, Haynes WG.

    Clin Exp Hypertens. 2004 Oct-Nov;26(7-8):629-36. Review.PMID: 15702617 [PubMed - indexed for MEDLINE]Related articles

    22.

    Obesity-associated hypertension: new insights into mechanisms.

    Rahmouni K, Correia ML, Haynes WG, Mark AL.

    Hypertension. 2005 Jan;45(1):9-14. Epub 2004 Dec 6. Review.PMID: 15583075 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin.

    Rahmouni K, Morgan DA, Morgan GM, Liu X, Sigmund CD, Mark AL, Haynes WG.

    J Clin Invest. 2004 Sep;114(5):652-8.PMID: 15343383 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Leptin and the cardiovascular system.

    Rahmouni K, Haynes WG.

    Recent Prog Horm Res. 2004;59:225-44. Review.PMID: 14749504 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Adipose depot-specific modulation of angiotensinogen gene expression in diet-induced obesity.

    Rahmouni K, Mark AL, Haynes WG, Sigmund CD.

    Am J Physiol Endocrinol Metab. 2004 Jun;286(6):E891-5. Epub 2004 Jan 28.PMID: 14749209 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Brain effects of leptin: what intracellular mechanism?

    Rahmouni K.

    Curr Diab Rep. 2003 Dec;3(6):427-9. Review. No abstract available. PMID: 14611736 [PubMed - indexed for MEDLINE]Related articles

    27.

    Role of melanocortin-4 receptors in mediating renal sympathoactivation to leptin and insulin.

    Rahmouni K, Haynes WG, Morgan DA, Mark AL.

    J Neurosci. 2003 Jul 9;23(14):5998-6004.PMID: 12853417 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Intracellular mechanisms involved in leptin regulation of sympathetic outflow.

    Rahmouni K, Haynes WG, Morgan DA, Mark AL.

    Hypertension. 2003 Mar;41(3 Pt 2):763-7. Epub 2002 Dec 16.PMID: 12623993 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    A leptin-sympathetic-leptin feedback loop: potential implications for regulation of arterial pressure and body fat.

    Mark AL, Rahmouni K, Correia M, Haynes WG.

    Acta Physiol Scand. 2003 Mar;177(3):345-9. Review.PMID: 12609005 [PubMed - indexed for MEDLINE]Related articles

    30.

    Leptin and the central neural mechanisms of obesity hypertension.

    Rahmouni K, G Haynes W.

    Drugs Today (Barc). 2002 Dec;38(12):807-17. Review.PMID: 12582470 [PubMed - indexed for MEDLINE]Related articles

    31.

    Influence of sodium intake on the cardiovascular and renal effects of brain mineralocorticoid receptor blockade in normotensive rats.

    Rahmouni K, Barthelmebs M, Grima M, Imbs JL, De Jong W.

    J Hypertens. 2002 Sep;20(9):1829-34.PMID: 12195126 [PubMed - indexed for MEDLINE]Related articles

    32.

    Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications.

    Mark AL, Correia ML, Rahmouni K, Haynes WG.

    J Hypertens. 2002 Jul;20(7):1245-50. Review.PMID: 12131511 [PubMed - indexed for MEDLINE]Related articles

    33.

    Cardiovascular and sympathetic effects of leptin.

    Rahmouni K, Haynes WG, Mark AL.

    Curr Hypertens Rep. 2002 Apr;4(2):119-25. Review.PMID: 11884267 [PubMed - indexed for MEDLINE]Related articles

    34.

    Selective resistance to central neural administration of leptin in agouti obese mice.

    Rahmouni K, Haynes WG, Morgan DA, Mark AL.

    Hypertension. 2002 Feb;39(2 Pt 2):486-90.PMID: 11882595 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.

    Rahmouni K, Sibug RM, De Kloet ER, Barthelmebs M, Grima M, Imbs JL, De Jong W.

    Eur J Pharmacol. 2002 Feb 2;436(3):207-16.PMID: 11858800 [PubMed - indexed for MEDLINE]Related articles

    36.

    The concept of selective leptin resistance: evidence from agouti yellow obese mice.

    Correia ML, Haynes WG, Rahmouni K, Morgan DA, Sivitz WI, Mark AL.

    Diabetes. 2002 Feb;51(2):439-42.PMID: 11812752 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Leptin signaling pathways in the central nervous system: interactions between neuropeptide Y and melanocortins.

    Rahmouni K, Haynes WG.

    Bioessays. 2001 Dec;23(12):1095-9. Review.PMID: 11746228 [PubMed - indexed for MEDLINE]Related articles

    38.

    Involvement of brain mineralocorticoid receptor in salt-enhanced hypertension in spontaneously hypertensive rats.

    Rahmouni K, Barthelmebs M, Grima M, Imbs JL, De Jong W.

    Hypertension. 2001 Oct;38(4):902-6.PMID: 11641306 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Brain mineralocorticoid receptors and centrally regulated functions.

    de Kloet ER, Van Acker SA, Sibug RM, Oitzl MS, Meijer OC, Rahmouni K, de Jong W.

    Kidney Int. 2000 Apr;57(4):1329-36. Review.PMID: 10760063 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Cardiovascular and renal effects of central administration of a mineralocorticoid receptor antagonist in conscious female rats.

    Rahmouni K, Barthelmebs M, Grima M, Imbs JL, De Jong W.

    Eur J Pharmacol. 1999 Dec 3;385(2-3):199-202.PMID: 10607876 [PubMed - indexed for MEDLINE]Related articles

    41.

    Brain mineralocorticoid receptor control of blood pressure and kidney function in normotensive rats.

    Rahmouni K, Barthelmebs M, Grima M, Imbs JL, Wybren De Jong.

    Hypertension. 1999 May;33(5):1201-6.PMID: 10334812 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    [Brain mineralocorticoid receptor and blood pressure control in the conscious normotensive rat]

    Rahmouni K, Barthelmebs M, Imbs JL, De Jong W.

    Arch Mal Coeur Vaiss. 1998 Aug;91(8):1009-12. French. PMID: 9749155 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...